[Epidermal Growth Factor Receptor-mutated Advanced Lung Adenocarcinoma with Long-term Tumor-free Survival by Chemotherapy Followed by Tyrosine Kinase Inhibitor Treatment after Reduction Surgery].
Kyobu Geka
; 69(13): 1051-1054, 2016 Dec.
Article
em Ja
| MEDLINE
| ID: mdl-27909271
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Adenocarcinoma
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Receptores ErbB
/
Neoplasias Pulmonares
Idioma:
Ja
Ano de publicação:
2016
Tipo de documento:
Article